3 active not recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 3 |
Follow IgA Nephropathy: new trials by email Literature Review of IgA Nephropathy trials Research Report on IgA Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Zigakibart in Adults With IgA Nephropathy BION-1301, Placebo - IgA Nephropathy, Immunoglobulin A Nephropathy | Phase 3 | Active not recruiting | Novartis Pharmaceuticals | 383 | 2023-07-06 | 2026-04-01 |
| Atacicept in Subjects With IgA Nephropathy Atacicept, Placebo to match Atacicept - IgA Nephropathy, Berger Disease | Phase 3 | Active not recruiting | Vera Therapeutics, Inc. | 428 | 2023-06-29 | 2026-10-01 |
| Atrasentan in Patients With IgA Nephropathy Atrasentan, Placebo, Zigakibart - IgA Nephropathy, Immunoglobulin A Nephropathy | Phase 3 | Active not recruiting | Novartis Pharmaceuticals | 404 | 2020-12-11 | 2026-06-04 |
Glomerulonephritis, IGA (3) · Glomerulonephritis (2) · Kidney Diseases (2) · Renal Insufficiency, Chronic (2) · Urologic Diseases (2)
Autoimmune Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Immune System Diseases (3) · Male Urogenital Diseases (3) · Nephritis (3) · Urogenital Diseases (3) · Chronic Disease (2) · Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Renal Insufficiency (2) · Glomerulonephritis (1) · Kidney Diseases (1) · Urologic Diseases (1)
Atrasentan (1) · TACI receptor-IgG Fc fragment fusion protein (1)
Novartis Pharmaceuticals (2) · Vera Therapeutics, Inc. (1)
United States (3) · Argentina (2) · Australia (2) · Brazil (2) · Canada (2) · China (2) · France (2) · Germany (2) · India (2) · Italy (2) · Japan (2) · South Korea (2) · Spain (2) · Taiwan (2) · United Kingdom (2)
Eric Michael, MD (1)
PMID 38059359, PMID 38299639, PMID 39460694, PMID 39462308, PMID 40465397, PMID 40482854, PMID 41196369, PMID 41442197, PMID 41620980, PMID 42205925, PMID 42242268